Pharmocann Global (XTAE:PMCN-M) EV-to-EBITDA : -0.11 (As of May. 07, 2024)

Pharmocann Global EV-to-EBITDA Chart

Pharmocann Global Annual Data
	Trend	Dec09	Dec10	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBITDA		Get a 7-Day Free Trial					-3.67	17.24	-1.69	-0.44	-0.26

Pharmocann Global Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															-1.42	-0.37	-0.44	-0.19	-0.26

Competitive Comparison of Pharmocann Global's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmocann Global's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmocann Global's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmocann Global's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Pharmocann Global's EV-to-EBITDA falls into.

Pharmocann Global EV-to-EBITDA Calculation

Pharmocann Global's EV-to-EBITDA for today is calculated as:

Pharmocann Global's current Enterprise Value is ₪1.63 Mil.
Pharmocann Global's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-15.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmocann Global  (XTAE:PMCN-M) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Pharmocann Global's PE Ratio for today is calculated as:

Pharmocann Global's share price for today is ₪1.074.
Pharmocann Global's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-17.168.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Pharmocann Global EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Pharmocann Global's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmocann Global (XTAE:PMCN-M) Business Description